Free company analysis covering financials, risk flags, competitive position, and opportunity scoring. World's largest independent biotechnology company. Approximately $33B revenue across oncology, inflammation, cardiovascular, and rare-disease franchises. Acquired Horizon Therapeutics for $28B to anchor rare-disease growth (Tepezza, Krystexxa). Obesity candidate MariTide positioning in the GLP-1 race.
World's largest independent biotechnology company. Approximately $33B revenue across oncology, inflammation, cardiovascular, and rare-disease franchises. Acquired Horizon Therapeutics for $28B to anchor rare-disease growth (Tepezza, Krystexxa). Obesity candidate MariTide positioning in the GLP-1 race.
Free 1-page brief delivered in minutes. Full 20-page report available for purchase.
Get Free Brief → Buy Full Report ($39.20 launch)